Virtual Research Reception: Evan Zahn, MD
HOPE THAT INNOVATES: Minimally Invasive Therapy for CHD Patients—FDA Approved Amplatzer Piccolo™ Occluder + Transcatheter Valves and Beyond
On June 2 from 5-7 pm CT, we are honored to host Dr. Evan Zahn, interventional cardiologist and director of the Congenital Heart Program and the Division of Pediatric Cardiology at Cedars-Sinai Smidt Heart Institute in Los Angeles. He will discuss minimally invasive therapies for CHD patients, including his very own FDA-approved Amplatzer Piccolo™ Occluder, along with transcatheter valves and more. Following his presentation, Dr. Zahn will lead an exclusive 30-minute Q&A session with attendees.